Beta-1 Adrenergic Inhibition (BADCATS trial)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Beta-1 Adrenergic Inhibition (BADCATS trial), covering 2024-11-26 to 2024-11-26. Get the full timeline:
Most recent: Clinical Trial Update: Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS) [Phase 4]